Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|RO7284755||RO-7284755|RO 7284755|PD1-IL2v||Immune Checkpoint Inhibitor 135 PD-L1/PD-1 antibody 80||RO7284755 consists of an alternate form of the cytokine IL-2 (IL-2v) fused to an antibody against PD-1, which may inhibit PD-1-mediated immune suppression and lead to activation of anti-tumor immune response (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04303858||Phase I||Atezolizumab + RO7284755 RO7284755||A Study to Evaluate Safety and Anti-Tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors||Recruiting||CAN||5|